SynthesisBMC oral health2026
Grading the evidence for the association between periodontal disease and chronic non-communicable diseases: an umbrella review of meta-analyses of observational studies.
Synthesis in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSubstantial but inconsistent evidence has implicated periodontal disease (PD) as a potential risk factor for multiple chronic non-communicable diseases (NCDs), but the overall quality and credibility of this evidence have not been systematically evaluated and quantified in aggregate. We thus systematically assessed the associations between PD and the risk of chronic NCDs.
methodsFollowing PRISMA guidelines, we searched PubMed, Embase, Cochrane, and Web of Science for meta-analyses of observational studies. Methodological quality was assessed with AMSTAR 2. Summary effects were recalculated using random-effects models, with heterogeneity and bias evaluated via I
resultsThirty-eight meta-analyses with 58 associations across nine disease categories were included. Eighty-one percent of associations were significant (P < 0.05), and 25.9% remained significant at P < 10⁻⁶. However, only 11 associations (18.9%) had 95% prediction intervals excluding the null value, indicating limited robustness and substantial between-study heterogeneity for most associations. Four associations (6.9%) provided highly suggestive evidence (Class II), namely Helicobacter pylori infection, urogenital cancer, total cancer, and oral cancer. Three of these four Class II associations had 95% prediction intervals excluding the null value, whereas total cancer did not (95% PI, 0.98-1.32). None of the four Class II associations was supported by a representative meta-analysis rated as high quality by AMSTAR 2. In exploratory subgroup analysis, the oral cancer association weakened and was downgraded from Class II to Class IV when restricted to objective clinical/radiographic PD definitions. Methodological quality was limited, with 26 of 38 included meta-analyses (68.4%) rated as low or critically low quality. The overall evidence base should be interpreted cautiously.
conclusionsThis umbrella review found statistically highly suggestive evidence linking PD to an increased risk of a limited number of chronic NCDs, namely Helicobacter pylori infection, urogenital cancer, total cancer, and oral cancer. However, total cancer did not have a 95% prediction interval excluding the null value, and none of the four Class II associations was supported by a high-quality representative meta-analysis; moreover, the oral cancer association weakened and was downgraded to Class IV under objective clinical/radiographic PD definitions. These findings should therefore be interpreted cautiously, and PD should be regarded as a statistically associated factor across a limited set of chronic NCDs, with insufficient evidence to support causal or modifiable interpretation.
trial registrationPROSPERO CRD420251009702.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.